Women with chronic non-communicable diseases are at higher risk of adverse pregnancy outcomes, which may be minimized through optimal preconception care and appropriate contraceptive use. Information on the contraceptive use and affecting factors among women with chronic non-communicable diseases in Ethiopia is rare. The objective of this study was to assess the magnitude of contraceptive use and associated factors among women with chronic non-communicable diseases in Addis Ababa’s, public hospitals. A hospital based cross-sectional study was performed on 357 women with chronic non-communicable diseases. Systematic sampling method was used to select the study participants. The Data were collected using interviewer administered structured questionnaires and was analysed using SPSS version 20.0. Bivariate and multivariate logistic regression at 95% CI and P < 0.05 was used to determine the final predictor in the model. Of the total women, only 124(34.2%) were contraceptive users. Majority of women with chronic non-communicable diseases were diabetic 140(39.2%), and hypertensive 134(37.5%). Those who discussed with their husband and got counselling were higher contraceptive users with AOR=2.5, 95% CI :( 1.3, 5.1) and AOR= 3.6, 95% CI (1.6, 8) respectively. Discussion with husband and counselling about contraceptive use were found the main predictors of contraceptive use.
Chronic non-communicable diseases, Diabetes, Hypertension, contraceptives, Addis Ababa.
2. Chuang CH, Velott DL and Weisman CS. Exploring knowledge and attitudes related to pregnancy and preconception health in women with chronic medical conditions. Maternal and Child Health Journal, 2010, 14:713–719.
3. Declaration B. Platform for Action (1995) Fourth World Conference on Women A. InCONF (Vol. 177, p. 20).
4. Cunningham F G, Leveno KL, Bloom SL, Hauth JC, Gilstrap III LC and Wenstrom KD. Hypertensive Disorders in Pregnancy: Introduction: McGraw-Hill. (www.ashjournal.com/article/S1933-1711(08)00185-X/fulltext). 2005
5. Domènecha AP and Gatzoulisb MA. Pregnancy and heart disease. Rev EspCardiol, 2006; 59(9), 971-984.
6. Ethiopian demographic and Health survey Addis Ababa, Ethiopia, CSAE’ March 2012. availablehttp://ethiopia.usaid.gov demographic health survey Addis Ababa.pdf(accessed in November 2013) .
7. Klima CS. Unintended pregnancy: consequences and solutions for a worldwide problem. Journal of Nurse-Midwifery, 1998; 43(6), 483-491. http://dx.doi.org/10.1016/S0091-2182(98)00063-9
8. Kuroki L M, Allsworth J E, Redding C A, Blume J D and Peipert J F. Is a previous unplanned pregnancy a risk factor for a subsequent unplanned pregnancy? American Journal of obstetrics and gynecology, 2008; 199(5), 517. e511-517.
9. Aghajanian A, Mehryar AH, Delavar B, Kazemipour S and Zinab HE. Continuing use of withdrawal as a contraceptive method in Iran. Canadian Studies in Population. 2007 31;34(2):179-90.
10. Kjos SL. Contraception for women with medical problems. Infertility and Reproductive Medicine Clinics of North America. 2000; 11(4):551-86.
11. Rosliza A, Irmi Z and Latiffah A. Contraceptive Use among Women with Chronic Medical Conditions and Factors Associated with Its Non-Use in Malaysia, Global Journal of Health Science; 2012: 4(5) 17.
12. Bitto A, Gray RH, Simpson JL, Queenan JT, Kambic RT, Perez A,Mena P, Barbato M, Li C and Jennings V.Adverse outcomes of planned and unplanned pregnancies among users of natural family planning: A prospective study. American Journal of Public Health. 1997; 87:338–343.
13. James PJ, Younger MD, Hamilton BD and Waisbren SE. Unplanned pregnancies in young women with diabetes. An analysis of psychosocial factors. Diabetes Care.1993; 16:1572–1578.
14. Chuang CH, Chase GA, Bensyl DM and Weisman CS. Contraceptive use by diabetic and obese women. Women’s Health Issues. 2005; 15:167–173.
15. Vahratian A, Barber JS, Lawrence JM and Kim C. Family-planning practices among women with diabetes and overweight and obese women in the 2002 National Survey for Family Growth. Diabetes Care. 2009; 32:1026–1031.
16. Global Health Risks http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_part2.pdf (accessed June, 2017)
17. Fajumi JO. Alterations in blood lipids and side effects induced by Depo=Provera in Nigerian women. Contraception. 1983; 27:161
18. Erfani A. The use of withdrawal among birth limiters in Iran and Turkey. Calverton, Maryland, ICF Macro 2010 (DHS Working Papers No. 71). (dhsprogram.com/pubs/pdf/WP71/WP71[revised_Yuan_22 April 2011.pdf)
19. Nojomi M, Morrovatdar MI, Davoudi F and Hosseini S. Contraceptive use by Iranian women with hypertension, diabetes or obesity . Eastern Mediterranean Health Journal. 2013; 638:19(7)
20. The 2007 Population and Housing Census of Ethiopia: Statistical Report for Addis Ababa City Administration (www.etharc.org/resources/download/view.download/68/381)
21. Rogers P, Mansour D, Mattinson A and O'Sullivan JJ. A collaborative clinic between contraception and sexual health services and an adult congenital heart disease clinic. Journal of Family Planning and Reproductive Health Care, 2007; 33(1), 17-21. http://dx.doi.org/10.1783/147118907779399648
22. Ministry of Health Republic of Indonesia. (2003). Reproductive Health Profile of Republic of Indonesia. Retrieved 30 July 2012, from http://www.searo.who.int/EN/Section13/Section36/Section1579_6415.htm
23. World Health Organization 2011. Women and health in the Western Pacific Region: remaining challenges and new opportunities. Retrieved 10 July 2012 from http://www.wpro.who.int/reproductive_health/data/en/
24. Nwachukwu I and Obasi OO. Use of modern birth control methods among rural communities in Imo State, Nigeria. African Journal of Reproductive Health. 2008;12(1):101-8.
25. Tawiah EO. Factors Affecting Contraceptive use in Ghana. Regional Institute for Population Studies, University of Ghana, Legon, Ghana, Journal of biosocial science, 1997. (journals.cambridge.org/production/action/cjoGetFulltext?fulltextid)
26. Boulay M and Valente TW. The relationship of social affiliation and intrapersonal discussion to family planning knowledge, attitudes and practice, International Family Planning Perspectives, 1999, 25(3):112-118.